October 18, 2007
Hologic stockholders approve Cytyc buy
By Matthew L. Brown
Stockholders of Bedford-based Hologic Inc. approved the company's $6.2 billion purchase of Marlborough's Cytyc Corp.
According to Hologic, more than 90 percent of shares represented at a meeting of stockholders this morning were voted in favor of the merger. The companies expect the deal to close next week. Under terms of the deal, Cytyc stockholders will receive slightly more than a half-share of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own.
Both companies are women's health care diagnostic equipment and services developers.
According to Hologic, more than 90 percent of shares represented at a meeting of stockholders this morning were voted in favor of the merger. The companies expect the deal to close next week. Under terms of the deal, Cytyc stockholders will receive slightly more than a half-share of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own.
Both companies are women's health care diagnostic equipment and services developers.
WBJ Web Partners
Most Recent
Most Recent
0 Comments